News

News | Jun 06, 2019

Ristela, a plant-based product aimed at menopausal women that promises to increase sexual pleasure, was introduced on the women’s wellness website Bonafide a few weeks ago. Bonafide said that sales of Ristela in its first 10 days surpassed expectations for three months, and another menopause-focused product is planned for early next year.

Press Release | Jun 04, 2019

Colorescience® announces the published results of their study “Beyond sun protection factor: An approach to environmental protection with novel mineral coatings in a vehicle containing a blend of skincare ingredients” in The Journal of Cosmetic Dermatology, that assessed the efficacy of their proprietary EnviroScreen™ technology – a novel, patented formulation that fights against both sun

Press Release | May 23, 2019

Kelly Williams, Founding Chair and co-CEO of PEWIN said of the awards, “PEWIN is so pleased to recognize Luminate Capital, 1315 Capital, the Teacher Retirement System of Texas and The Riverside Company, each of whom are leading by example in their support, promotion and amplification of the outstanding women investors who exist in the private

Press Release | May 17, 2019

Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has completed its previously announced bought deal public offering and concurrent private placement (the “Offerings”) for total gross proceeds of C$30,579,250. The Offerings were both completed on a bought deal

News | May 07, 2019

At the Bloom Burton & Co. Healthcare Investor Conference in Toronto, which took place from April 30 to May 1, experts in the industry sat down for a panel discussion called “Investing in Commercial Stage Healthcare Companies.” They focused largely on drug price issues in the US, political implications for the industry and the struggles

Press Release | May 02, 2019

Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC (“Solsys”), a privately held regenerative medical company, to acquire Solsys in an all-stock transaction valued at approximately $97 million. Under the terms of

News | Apr 08, 2019

Oliva will be honored with the 2019 Hall of Fame Award from SJU’s Haub School of Business on April 9, 2019 at The Union League of Philadelphia. A proud SJU grad, Oliva has been a healthcare investor for over 20 years and focuses on commercial stage medical technology, healthcare service, and specialty pharmaceutical investments. You

Press Release | Apr 08, 2019

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has provided a $20 million venture loan facility to Encore Dermatology, Inc. (“Encore”), of

Press Release | Apr 02, 2019

Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius

Pages 1 2 3 4 5 10